Vol 58, No 1 (2024)
Letter to the Editors
Published online: 2023-12-19
Cerebral amyloid angiopathy associated with Alzheimer’s Disease: two pathologies from a single peptide?
1
, 2, 3, 4
, 2, 3, 4
Abstract
Not available
Keywords: amyloidbrainangiopathyAlzheimer’s Disease
References
- Tipton PW. Updates on pharmacological treatment for Alzheimer's disease. Neurol Neurochir Pol. 2023 [Epub ahead of print].
- Smith EE. Cerebral amyloid angiopathy as a cause of neurodegeneration. J Neurochem. 2018; 144(5): 651–658.
- Greenberg SM, Bacskai BJ, Hernandez-Guillamon M, et al. Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways. Nat Rev Neurol. 2020; 16(1): 30–42.
- Ghiso J, Tomidokoro Y, Revesz T, et al. Cerebral amyloid angiopathy and alzheimer's disease. Hirosaki Igaku. 2010; 61 (Suppl): S111–S124.
- Jäkel L, De Kort AM, Klijn CJM, et al. Prevalence of cerebral amyloid angiopathy: A systematic review and meta-analysis. Alzheimers Dement. 2022; 18(1): 10–28.
